HomeINDGN • NSE
add
Indegene Ltd
Previous close
₹640.90
Day range
₹631.50 - ₹643.90
Year range
₹470.10 - ₹736.30
Market cap
153.60B INR
Avg Volume
427.48K
P/E ratio
38.31
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 6.87B | 8.04% |
Operating expense | 5.80B | 8.55% |
Net income | 917.00M | 22.27% |
Net profit margin | 13.35 | 13.14% |
Earnings per share | — | — |
EBITDA | 1.26B | 14.33% |
Effective tax rate | 26.11% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.67B | — |
Total assets | 30.24B | — |
Total liabilities | 6.64B | — |
Total equity | 23.60B | — |
Shares outstanding | 238.80M | — |
Price to book | 6.48 | — |
Return on assets | — | — |
Return on capital | 12.22% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 917.00M | 22.27% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. Wikipedia
CEO
Founded
1998
Website
Employees
4,367
